Literature DB >> 15808703

Nanotechnology approaches for the regeneration and neuroprotection of the central nervous system.

Gabriel A Silva1.   

Abstract

Nanotechnology is the science and engineering concerned with the design, synthesis, and characterization of materials and devices that have a functional organization in at least 1 dimension on the nanometer (ie, one-billionth of a meter) scale. The ability to manipulate and control engineered self-assembling (ie, self-organizing) substrates at these scales produces macroscopic physical and/or chemical properties in the bulk material not possessed by the constituent building block molecules alone. This in turn results in a degree of functional integration between the engineered substrates and cellular or physiological systems not previously attainable. Applied nanotechnology aimed at the regeneration and neuroprotection of the central nervous system (CNS) will significantly benefit from basic nanotechnology research conducted in parallel with advances in cell biology, neurophysiology, and neuropathology. Ultimately the goal is to develop novel technologies that directly or indirectly aid in providing neuroprotection and/or a permissive environment and active signaling cues for guided axon growth. In some cases, it is expected that the neurosurgeon will be required to administer these substrates to the patient. As such, in order for nanotechnology applications directed toward neurological disorders to develop to their fullest potential, it will be important for neuroscientists, neurosurgeons, and neurologists to participate and contribute to the scientific process alongside physical science and engineering colleagues. This review will focus on emerging clinical applications aimed at the regeneration and neuroprotection of the injured CNS, and discuss other platform technologies that have a significant potential for being adapted for clinical neuroscience applications.

Entities:  

Mesh:

Year:  2005        PMID: 15808703     DOI: 10.1016/j.surneu.2004.06.008

Source DB:  PubMed          Journal:  Surg Neurol        ISSN: 0090-3019


  15 in total

1.  Leptomeningeal collaterals in acute ischemic stroke.

Authors:  Nauman Tariq; Rakesh Khatri
Journal:  J Vasc Interv Neurol       Date:  2008-10

Review 2.  Novel nanomaterials for clinical neuroscience.

Authors:  Jamie L Gilmore; Xiang Yi; Lingdong Quan; Alexander V Kabanov
Journal:  J Neuroimmune Pharmacol       Date:  2008-01-22       Impact factor: 4.147

Review 3.  "Extremely minimally invasive": recent advances in nanotechnology research and future applications in neurosurgery.

Authors:  Tobias A Mattei; Azeem A Rehman
Journal:  Neurosurg Rev       Date:  2014-08-31       Impact factor: 3.042

4.  Nanotechnology for Neuroscience: Promising Approaches for Diagnostics, Therapeutics and Brain Activity Mapping.

Authors:  Anil Kumar; Aaron Tan; Joanna Wong; Jonathan Clayton Spagnoli; James Lam; Brianna Diane Blevins; Natasha G; Lewis Thorne; Keyoumars Ashkan; Jin Xie; Hong Liu
Journal:  Adv Funct Mater       Date:  2017-08-14       Impact factor: 18.808

Review 5.  Nanoparticle-Based Therapeutics for Brain Injury.

Authors:  Vimala N Bharadwaj; Duong T Nguyen; Vikram D Kodibagkar; Sarah E Stabenfeldt
Journal:  Adv Healthc Mater       Date:  2017-10-16       Impact factor: 9.933

Review 6.  Nanomedicine in Central Nervous System (CNS) Disorders: A Present and Future Prospective.

Authors:  Shringika Soni; Rakesh Kumar Ruhela; Bikash Medhi
Journal:  Adv Pharm Bull       Date:  2016-09-25

7.  Nanotechnology and surgical neurology.

Authors:  Rajiv Saini; Santosh Saini
Journal:  Surg Neurol Int       Date:  2010-09-16

Review 8.  Nanotechnology, nanotoxicology, and neuroscience.

Authors:  Won Hyuk Suh; Kenneth S Suslick; Galen D Stucky; Yoo-Hun Suh
Journal:  Prog Neurobiol       Date:  2008-09-24       Impact factor: 11.685

Review 9.  Nanogels as potential drug nanocarriers for CNS drug delivery.

Authors:  Arti Vashist; Ajeet Kaushik; Atul Vashist; Jyoti Bala; Roozbeh Nikkhah-Moshaie; Vidya Sagar; Madhavan Nair
Journal:  Drug Discov Today       Date:  2018-05-20       Impact factor: 7.851

10.  Binding fullerenol C(60)(OH)(24) to dsDNA.

Authors:  Mariana Pinteala; Andrei Dascalu; Cezar Ungurenasu
Journal:  Int J Nanomedicine       Date:  2009-09-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.